Sanofi-aventis reported to grow Cambridge presence

Thu, 07/08/2010 - 6:35am
Mass High Tech: The Journal of New England Technology

French drug developer Sanofi-aventis SA is growing its presence in Cambridge, with plans to add 300 jobs and a $65 million expansion investment, according to a report today in The Boston Globe. The company has a research and development facility in Cambridge.

Sanofi-aventis has a global presence in developing vaccines, prescription medicines, generics medicines, consumer health care and animal health care, according to its website.

The Globe article noted that Sanofi-aventis plans to “establish a joint headquarters for a new cancer division,” and its salaries are expected to pay more than $100,000 per year. 

In May, Sanofi-aventis added $500,000 in matching investments to local, early stage companies as part of a corporate consortium established by the Massachusetts Life Sciences Center. The money will be used to support MLSC’s Accelerator loan program, which provides funding to early stage life sciences companies.




Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.